p53: guardian of the genome and policeman of the oncogenes - PubMed

Affiliations

• PMID: 17457049
• DOI: 10.4161/cc.6.9.4211

Free article

Review

p53: guardian of the genome and policeman of the oncogenes

Alejo Efeyan et al. Cell Cycle. 2007.

Free article

Abstract

The process of malignant transformation universally entails genetic damage and oncogenic signaling, two stresses that are signaled to p53 through different genetic pathways. Based on this, it is possible to distinguish two jobs for p53: "guardian of the genome" that consists in sensing and reacting to DNA damage through the ATM/ATR and Chk1/Chk2 kinases, and "policeman of the oncogenes" that, correspondingly, consists in responding to oncogenic signaling through the p53-stabilizing protein ARF. Contrary to expectation, recent genetic evidence in mice indicates that the response of p53 to DNA damage has little or no impact on cancer protection. In contrast, ARF-dependent activation of p53 is critical for p53-mediated tumor suppression. Here, we discuss the mechanistic implications of these observations and their relevance for cancer therapy.

Similar articles

• ATR-Chk2 signaling in p53 activation and DNA damage response during cisplatin-induced apoptosis.

  Pabla N, Huang S, Mi QS, Daniel R, Dong Z. Pabla N, et al. J Biol Chem. 2008 Mar 7;283(10):6572-83. doi: 10.1074/jbc.M707568200. Epub 2007 Dec 27. J Biol Chem. 2008. PMID: 18162465

• p14ARF activates a Tip60-dependent and p53-independent ATM/ATR/CHK pathway in response to genotoxic stress.

  Eymin B, Claverie P, Salon C, Leduc C, Col E, Brambilla E, Khochbin S, Gazzeri S. Eymin B, et al. Mol Cell Biol. 2006 Jun;26(11):4339-50. doi: 10.1128/MCB.02240-05. Mol Cell Biol. 2006. PMID: 16705183 Free PMC article.

• Oncogenes and the DNA damage response: Myc and E2F1 engage the ATM signaling pathway to activate p53 and induce apoptosis.

  Hong S, Pusapati RV, Powers JT, Johnson DG. Hong S, et al. Cell Cycle. 2006 Apr;5(8):801-3. doi: 10.4161/cc.5.8.2638. Epub 2006 Apr 17. Cell Cycle. 2006. PMID: 16582589

• The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer.

  Smith J, Tho LM, Xu N, Gillespie DA. Smith J, et al. Adv Cancer Res. 2010;108:73-112. doi: 10.1016/B978-0-12-380888-2.00003-0. Adv Cancer Res. 2010. PMID: 21034966 Review.

• Exploiting synthetic lethal interactions for targeted cancer therapy.

  Reinhardt HC, Jiang H, Hemann MT, Yaffe MB. Reinhardt HC, et al. Cell Cycle. 2009 Oct 1;8(19):3112-9. doi: 10.4161/cc.8.19.9626. Cell Cycle. 2009. PMID: 19755856 Free PMC article. Review.

Cited by

• A Novel Anticancer Agent, 8-Methoxypyrimido[4',5':4,5]thieno(2,3-b) Quinoline-4(3H)-One Induces Neuro 2a Neuroblastoma Cell Death through p53-Dependent, Caspase-Dependent and -Independent Apoptotic Pathways.

  Sahu U, Sidhar H, Ghate PS, Advirao GM, Raghavan SC, Giri RK. Sahu U, et al. PLoS One. 2013 Jun 18;8(6):e66430. doi: 10.1371/journal.pone.0066430. Print 2013. PLoS One. 2013. PMID: 23824039 Free PMC article.

• Runt-related transcription factor RUNX3 is a target of MDM2-mediated ubiquitination.

  Chi XZ, Kim J, Lee YH, Lee JW, Lee KS, Wee H, Kim WJ, Park WY, Oh BC, Stein GS, Ito Y, van Wijnen AJ, Bae SC. Chi XZ, et al. Cancer Res. 2009 Oct 15;69(20):8111-9. doi: 10.1158/0008-5472.CAN-09-1057. Epub 2009 Oct 6. Cancer Res. 2009. PMID: 19808967 Free PMC article.

• Artemisinin derivative artesunate induces radiosensitivity in cervical cancer cells in vitro and in vivo.

  Luo J, Zhu W, Tang Y, Cao H, Zhou Y, Ji R, Zhou X, Lu Z, Yang H, Zhang S, Cao J. Luo J, et al. Radiat Oncol. 2014 Mar 25;9:84. doi: 10.1186/1748-717X-9-84. Radiat Oncol. 2014. PMID: 24666614 Free PMC article.

• ALDH3A1 Plays a Functional Role in Maintenance of Corneal Epithelial Homeostasis.

  Koppaka V, Chen Y, Mehta G, Orlicky DJ, Thompson DC, Jester JV, Vasiliou V. Koppaka V, et al. PLoS One. 2016 Jan 11;11(1):e0146433. doi: 10.1371/journal.pone.0146433. eCollection 2016. PLoS One. 2016. PMID: 26751691 Free PMC article.

• Pharmacological stimulation of p53 with low-dose doxorubicin ameliorates diet-induced nonalcoholic steatosis and steatohepatitis.

  Porteiro B, Fondevila MF, Buque X, Gonzalez-Rellan MJ, Fernandez U, Mora A, Beiroa D, Senra A, Gallego R, Fernø J, López M, Sabio G, Dieguez C, Aspichueta P, Nogueiras R. Porteiro B, et al. Mol Metab. 2018 Feb;8:132-143. doi: 10.1016/j.molmet.2017.12.005. Epub 2017 Dec 15. Mol Metab. 2018. PMID: 29290620 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal